251 related articles for article (PubMed ID: 31381154)
1. Platelet-rich fibrin suppresses in vitro osteoclastogenesis.
Kargarpour Z; Nasirzade J; Strauss FJ; Di Summa F; Hasannia S; Müller HD; Gruber R
J Periodontol; 2020 Mar; 91(3):413-421. PubMed ID: 31381154
[TBL] [Abstract][Full Text] [Related]
2. Constant hypoxia inhibits osteoclast differentiation and bone resorption by regulating phosphorylation of JNK and IκBα.
Ma Z; Yu R; Zhao J; Sun L; Jian L; Li C; Liu X
Inflamm Res; 2019 Feb; 68(2):157-166. PubMed ID: 30604211
[TBL] [Abstract][Full Text] [Related]
3. Liquid PRF Reduces the Inflammatory Response and Osteoclastogenesis in Murine Macrophages.
Kargarpour Z; Nasirzade J; Panahipour L; Miron RJ; Gruber R
Front Immunol; 2021; 12():636427. PubMed ID: 33897689
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
[TBL] [Abstract][Full Text] [Related]
5. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
6. Calcium-containing crystals enhance receptor activator of nuclear factor κB ligand/macrophage colony-stimulating factor-mediated osteoclastogenesis via extracellular-signal-regulated kinase and p38 pathways.
Chang CC; Tsai YH; Liu Y; Lin SY; Liang YC
Rheumatology (Oxford); 2015 Oct; 54(10):1913-22. PubMed ID: 25998451
[TBL] [Abstract][Full Text] [Related]
7. Platelet-rich fibrin/biphasic calcium phosphate impairs osteoclast differentiation and promotes apoptosis by the intrinsic mitochondrial pathway in chronic periodontitis.
Kumar A; Mahendra J; Samuel S; Govindraj J; Loganathan T; Vashum Y; Mahendra L; Krishnamoorthy T
J Periodontol; 2019 Jan; 90(1):61-71. PubMed ID: 29958327
[TBL] [Abstract][Full Text] [Related]
8. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
[TBL] [Abstract][Full Text] [Related]
9. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
Kanazawa K; Kudo A
J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
[TBL] [Abstract][Full Text] [Related]
10. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
11. Ameloblastin attenuates RANKL-mediated osteoclastogenesis by suppressing activation of nuclear factor of activated T-cell cytoplasmic 1 (NFATc1).
Chaweewannakorn W; Ariyoshi W; Okinaga T; Fujita Y; Maki K; Nishihara T
J Cell Physiol; 2019 Feb; 234(2):1745-1757. PubMed ID: 30105896
[TBL] [Abstract][Full Text] [Related]
12. Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1.
Ibáñez L; Nácher-Juan J; Terencio MC; Ferrándiz ML; Alcaraz MJ
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955685
[TBL] [Abstract][Full Text] [Related]
13. Deletion of CD74, a putative MIF receptor, in mice enhances osteoclastogenesis and decreases bone mass.
Mun SH; Won HY; Hernandez P; Aguila HL; Lee SK
J Bone Miner Res; 2013 Apr; 28(4):948-59. PubMed ID: 23044992
[TBL] [Abstract][Full Text] [Related]
14. Mineral trioxide aggregate (MTA) inhibits osteoclastogenesis and osteoclast activation through calcium and aluminum activities.
Rezende TMB; Ribeiro Sobrinho AP; Vieira LQ; Sousa MGDC; Kawai T
Clin Oral Investig; 2021 Apr; 25(4):1805-1814. PubMed ID: 32789653
[TBL] [Abstract][Full Text] [Related]
15. Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.
Kang JH; Ko HM; Moon JS; Yoo HI; Jung JY; Kim MS; Koh JT; Kim WJ; Kim SH
J Dent Res; 2014 Nov; 93(11):1116-23. PubMed ID: 25256714
[TBL] [Abstract][Full Text] [Related]
16. Modulating calcium-mediated NFATc1 and mitogen-activated protein kinase deactivation underlies the inhibitory effects of kavain on osteoclastogenesis and bone resorption.
Guo Q; Cao Z; Wu B; Chen F; Tickner J; Wang Z; Qiu H; Wang C; Chen K; Tan R; Gao Q; Xu J
J Cell Physiol; 2018 Jan; 234(1):789-801. PubMed ID: 30078210
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms involved in enhancement of osteoclast formation by activin-A.
Kajita T; Ariyoshi W; Okinaga T; Mitsugi S; Tominaga K; Nishihara T
J Cell Biochem; 2018 Aug; 119(8):6974-6985. PubMed ID: 29737562
[TBL] [Abstract][Full Text] [Related]
18. Neogambogic Acid Suppresses Receptor Activator of Nuclear Factor κB Ligand (RANKL)-Induced Osteoclastogenesis by Inhibiting the JNK and NF-κB Pathways in Mouse Bone Marrow-Derived Monocyte/Macrophages.
Jin G; Wang FF; Li T; Jia DD; Shen Y; Xu HC
Med Sci Monit; 2018 Apr; 24():2569-2577. PubMed ID: 29698379
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-3 plays dual roles in osteoclastogenesis by promoting the development of osteoclast progenitors but inhibiting the osteoclastogenic process.
Hong H; Shi Z; Qiao P; Li H; McCoy EM; Mao P; Xu H; Feng X; Wang S
Biochem Biophys Res Commun; 2013 Nov; 440(4):545-50. PubMed ID: 24103757
[TBL] [Abstract][Full Text] [Related]
20. Conditioned medium from fresh and demineralized bone enhances osteoclastogenesis in murine bone marrow cultures.
Caballé-Serrano J; Schuldt Filho G; Bosshardt DD; Gargallo-Albiol J; Buser D; Gruber R
Clin Oral Implants Res; 2016 Feb; 27(2):226-32. PubMed ID: 25754222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
